ePrivacy and GPDR Cookie Consent by TermsFeed Generator
Submit Your Proposal for the 2024 Cancer Research Grant. Deadline: May 1, 2024 |Apply Now

Industry Symposium + Breakfast

Unveiling the Power of 3D Genomics: Decoding Extreme Structural Heterogeneity in Glioblastoma

Wednesday, June 14, 2023 | 8:30 – 9:15 
Room 2 | Coffee and breakfast will be provided

In this session, dive into the fascinating world of 3D genomics and learn how this cutting-edge approach allows researchers to unravel novel disease mechanisms, identify therapeutic targets, and detect gene fusions crucial for cancer diagnostics.

Dr. Kristin Sikkink, Director of Research at Arima Genomics, will present compelling case studies demonstrating how 3D genomics identifies the genetic drivers of previously undiagnosed tumors. Joining her will be Dr. Argyris Papantonis, Professor for Translational Epigenetics at the University of Goettingen in Germany. Dr. Papantonis will illuminate our understanding of the spatial organization of glioblastoma genomes, elucidating its impact on tumor heterogeneity and providing valuable insights for targeted therapies.

Don’t miss this opportunity to explore the exciting possibilities that 3D genomics brings to cancer research and beyond! Coffee and breakfast will be provided.

Save Your Seat

Meet the Speakers:

Kristin Sikkink, PhD

Director of Research, Arima Genomics

Kristin is our newly appointed Director of Research and holds a PhD in Biology. She leads and manages Arima's clinical and discovery research programs.

Argyris Papantonis, PhD

Professor for Translational Epigenetics, University of Goettingen in Germany

Argyris studied biology at the University of Athens, where he also obtained his Ph.D. Following postdoctoral work with Peter R. Cook at the University of Oxford, he set up his lab at the Center for Molecular Medicine Cologne, Germany. Since 2018 he is a Professor for Translational Epigenetics at the Medical Faculty of the University of Goettingen, Germany.

Stop by our Poster Session:

Uncovering Gene Fusions with 3D Genomics: From Clinical Validation to
Actionable Insights for Undiagnosable Solid Tumors

Abstract Number: EACR23-1524
Tuesday, June 13, 2023 | 17:00 – 18:00 
During Poster Session: Biomarkers in Tissue and Blood (even Abstracts Numbers)

Kristin Sikkink, PhD

Director of Research, Arima Genomics